Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$857,129,238
+$234,557,561 QoQ
Shares Held
7,474,747
0.0% QoQ
Ownership
8.99%
of shares outstanding
% of Portfolio
7.70%
of 13F equity value
Holder Rank
#3
of 275 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Avoro Capital Advisors LLC holds $9,631,167,263 across 25 Biotechnology names. KYMR ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,111,111 | $1,363,235,525 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $1,073,713,002 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,833,333 | $984,408,154 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $927,770,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
11,355,555 | $925,591,288 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
This page
|
7,474,747 | $857,129,238 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,297,000 | $430,182,160 | |
| 8 | CYTK |
Cytokinetics Inc
|
4,999,999 | $425,949,914 |
All Filings in KYMR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $857,129,238 | 7,474,747 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $622,571,677 | 7,474,747 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $581,610,064 | 7,474,747 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $359,410,000 | 6,350,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $286,084,420 | 6,555,555 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $176,810,200 | 6,460,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $207,184,500 | 5,150,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $212,985,000 | 4,500,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $116,083,306 | 3,888,888 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $156,333,297 | 3,888,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $96,111,500 | 3,775,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,584,500 | 3,855,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $88,626,450 | 3,855,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $114,223,650 | 3,855,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $96,096,000 | 3,850,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,224,137 | 2,169,230 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,809,400 | 1,260,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,554,280 | 816,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,919,500 | 550,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,770,755 | 455,750 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $1,596,114 | 49,400 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||